D.E. Shaw & Co’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,821
| Closed | -$202K | – | 4078 |
|
|
2022
Q2 | $202K | Buy |
9,821
+1,215
| +14% | +$25K | ﹤0.01% | 3398 |
|
|
2022
Q1 | $324K | Buy |
8,606
+5,440
| +172% | +$205K | ﹤0.01% | 3413 |
|
|
2021
Q4 | $305K | Buy |
3,166
+1,858
| +142% | +$179K | ﹤0.01% | 3307 |
|
|
2021
Q3 | $189K | Buy |
+1,308
| New | +$189K | ﹤0.01% | 3264 |
|
|
2021
Q1 | – | Sell |
-857
| Closed | -$242K | – | 3107 |
|
|
2020
Q4 | $242K | Buy |
+857
| New | +$242K | ﹤0.01% | 2508 |
|
|
2020
Q3 | – | Sell |
-1,650
| Closed | -$548K | – | 2706 |
|
|
2020
Q2 | $548K | Buy |
1,650
+17
| +1% | +$5.65K | ﹤0.01% | 2119 |
|
|
2020
Q1 | $372K | Sell |
1,633
-2,943
| -64% | -$670K | ﹤0.01% | 2258 |
|
|
2019
Q4 | $1.13M | Sell |
4,576
-1,282
| -22% | -$316K | ﹤0.01% | 1861 |
|
|
2019
Q3 | $334K | Sell |
5,858
-460
| -7% | -$26.2K | ﹤0.01% | 2231 |
|
|
2019
Q2 | $298K | Hold |
6,318
| – | – | ﹤0.01% | 2305 |
|
|
2019
Q1 | $341K | Sell |
6,318
-8,914
| -59% | -$481K | ﹤0.01% | 2223 |
|
|
2018
Q4 | $658K | Sell |
15,232
-131
| -0.9% | -$5.66K | ﹤0.01% | 2008 |
|
|
2018
Q3 | $900K | Buy |
15,363
+13,936
| +977% | +$816K | ﹤0.01% | 1864 |
|
|
2018
Q2 | $76K | Buy |
1,427
+394
| +38% | +$21K | ﹤0.01% | 2512 |
|
|
2018
Q1 | $291K | Buy |
1,033
+104
| +11% | +$29.3K | ﹤0.01% | 2255 |
|
|
2017
Q4 | $218K | Buy |
929
+375
| +68% | +$88K | ﹤0.01% | 2371 |
|
|
2017
Q3 | $157K | Buy |
+554
| New | +$157K | ﹤0.01% | 2374 |
|